Article citationsMore>>

Gerber, D.E., Camidge, D.R., Morgensztern, D., et al. (2020) Phase 2 Study of the Focal Adhesion Kinase Inhibitor Defactinib (VS-6063) in Previously Treated Advanced KRAS Mutant Non-Small Cell Lung Cancer. Lung Cancer, 139, 60-67.
https://doi.org/10.1016/j.lungcan.2019.10.033

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top